News
Four months after ditching its lead drug, a small Peninsula biotech with less than $40 million on hand hopes to rev up ...
We recently published a list of Billionaire Stanley Druckenmiller’s Top 10 Stocks Picks with Huge Upside Potential.
Piramal Pharma Limited (PPL) is a leading pharmaceutical company and part of the Piramal Group. The company was established ...
Ned Sharpless, a renowned cancer researcher and former National Cancer Institute director, is back in Chapel Hill with a new ...
Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...
President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs ...
Is the biotech job market improving in 2025? Explore the latest trends and opportunities in the industry after a challenging few years.
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report) dropped 5.3% during trading on Thursday . The company traded as low as $1.23 and last traded at $1.25. Approximately 18,546 shares changed ...
Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.
Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.
Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...
which aids biotech companies in growing, attracting venture capital, and accelerating drug development. Analysts predict that a rate decline might free up billions of dollars in investment money ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results